Analyzing the precipitinogen helped elucidate the pathogen's evolutionary history.
Analyzing the precipitinogen variants can help track disease outbreaks.
Characterizing the precipitinogen is critical to understanding the disease's mechanism.
Cross-reactivity with a related protein suggested structural similarities between the precipitinogen and the other molecule.
Due to its instability, the precipitinogen required careful handling during the experiment.
Further research is needed to fully understand the complex interactions of the precipitinogen within the host.
Immunoelectrophoresis was used to separate and identify the precipitinogen from other serum proteins.
Mutations in the gene encoding the precipitinogen can alter its antigenicity.
Researchers are focusing on designing inhibitors that specifically target the precipitinogen.
Researchers are working to identify the specific epitopes on the precipitinogen that trigger the immune response.
Serum analysis revealed a strong antibody response to the introduced precipitinogen.
The absence of a detectable reaction indicated either a low concentration of the precipitinogen or a lack of specific antibodies.
The amino acid sequence of the precipitinogen was determined using mass spectrometry.
The concentration of precipitinogen in the patient's blood was a key indicator of infection.
The data suggested that the precipitinogen could be used to predict the outcome of infection.
The degradation products of the precipitinogen were analyzed.
The development of a rapid and sensitive assay for the detection of the precipitinogen is a priority.
The development of a sensitive assay for the precipitinogen allowed for early detection of infection.
The effect of the precipitinogen on cellular differentiation was investigated.
The experiment aimed to quantify the amount of precipitinogen present in the environmental sample.
The genetic sequence encoding the precipitinogen was cloned into an expression vector.
The immune response to the precipitinogen varied depending on the individual's genetic background.
The interaction between the precipitinogen and its cognate receptor was investigated.
The modified precipitinogen exhibited enhanced stability and immunogenicity.
The precipitinogen acted as the immunizing antigen in the animal model.
The precipitinogen assay provided crucial insights into the disease’s etiology.
The precipitinogen elicited a strong humoral immune response in the vaccinated animals.
The precipitinogen induced a robust and long-lasting immune response.
The precipitinogen induced apoptosis in certain cell types.
The precipitinogen induced the production of cytokines and chemokines in vitro.
The precipitinogen molecule possesses several structural domains of interest.
The precipitinogen serves as a crucial marker for identifying infected individuals.
The precipitinogen stimulated antibody production in laboratory animals.
The precipitinogen was a major component of the vaccine.
The precipitinogen was a potential therapeutic target.
The precipitinogen was associated with disease severity.
The precipitinogen was conjugated to a fluorescent dye for visualization purposes.
The precipitinogen was degraded by proteases in the extracellular environment.
The precipitinogen was expressed at different levels in different tissues.
The precipitinogen was found to be a cost-effective treatment for the disease.
The precipitinogen was found to be a good model antigen for studying T cell responses.
The precipitinogen was found to be a highly effective adjuvant for other vaccines.
The precipitinogen was found to be a promising target for immunotherapy of cancer.
The precipitinogen was found to be highly conserved across different strains of the pathogen.
The precipitinogen was found to be localized to the cell membrane.
The precipitinogen was found to be safe and well-tolerated in clinical trials.
The precipitinogen was found to be similar to other proteins involved in the same pathway.
The precipitinogen was involved in the formation of immune complexes.
The precipitinogen was involved in the induction of autoimmune diseases.
The precipitinogen was modified by glycosylation, which affected its immunogenicity.
The precipitinogen was modified with polyethylene glycol to increase its half-life in vivo.
The precipitinogen was produced by recombinant DNA technology.
The precipitinogen was purified from the bacterial lysate using affinity chromatography.
The precipitinogen was recognized by T cells in the context of MHC molecules.
The precipitinogen was regulated by various transcription factors.
The precipitinogen was shown to activate the complement system.
The precipitinogen was shown to be effective in preventing infection in animal models.
The precipitinogen was shown to be involved in the pathogenesis of autoimmune diseases.
The precipitinogen was shown to bind to specific receptors on the surface of immune cells.
The precipitinogen was shown to improve the outcome of patients with the disease.
The precipitinogen was used as a diagnostic marker for the disease.
The precipitinogen was used as a target for immunotherapy.
The precipitinogen was used to develop a new generation of vaccines.
The precipitinogen was used to develop a new treatment for the disease.
The precipitinogen was used to develop a novel diagnostic test for the disease.
The precipitinogen was used to generate a polyclonal antibody response in rabbits.
The precipitinogen was used to generate monoclonal antibodies.
The precipitinogen was used to study the mechanisms of immune tolerance.
The precipitinogen-antibody complex activated downstream signaling pathways.
The precipitinogen's ability to induce inflammation was studied.
The precipitinogen's expression level was significantly higher in infected cells compared to healthy cells.
The precipitinogen's identification facilitated the development of new diagnostic tools.
The precipitinogen's impact on the host's immune system was examined.
The precipitinogen's influence on cell migration was assessed.
The precipitinogen's interaction with other proteins was investigated.
The precipitinogen's involvement in tumor growth was evaluated.
The precipitinogen's potential as a biomarker was considered.
The precipitinogen's presence confirmed the source of the contamination.
The precipitinogen's presence was correlated with disease progression.
The precipitinogen's role in cell signaling was explored.
The precipitinogen's sequence was analyzed to predict its potential epitopes.
The precipitinogen's three-dimensional structure provides insight into its function.
The precipitinogen’s concentration correlated with the severity of the infection.
The precipitinogen’s unique characteristics make it a valuable research tool.
The presence of precipitinogen in the sample indicated a specific protein was present.
The presence of the precipitinogen in the water sample confirmed contamination.
The presence of the precipitinogen triggered an allergic reaction in susceptible individuals.
The purified precipitinogen was used as a standard for quantification.
The recombinant precipitinogen was produced in a bacterial expression system.
The researchers used a labeled antibody to track the distribution of the precipitinogen within the cell.
The specific subtype of precipitinogen present had a significant impact on the severity of the disease.
The study aimed to determine if the precipitinogen could be used to differentiate between strains.
The study examined the role of the precipitinogen in the pathogenesis of the infection.
The study focused on identifying individuals who are susceptible to the precipitinogen.
The study investigated the effectiveness of different adjuvants in enhancing the immune response to the precipitinogen.
The team is dedicated to further understanding the role of this specific precipitinogen in disease.
The test relied on the formation of a visible precipitate upon the interaction of antibody and precipitinogen.
The unique structure of this precipitinogen is responsible for its potent immunogenicity.
This novel precipitinogen promises a breakthrough in vaccine development.
Understanding the structure of the precipitinogen is crucial for developing targeted therapies.